SPALLONE, VINCENZA
 Distribuzione geografica
Continente #
NA - Nord America 38.414
EU - Europa 4.155
AS - Asia 1.522
SA - Sud America 127
OC - Oceania 66
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 13
Totale 44.311
Nazione #
US - Stati Uniti d'America 38.267
IT - Italia 1.570
SG - Singapore 629
UA - Ucraina 545
DE - Germania 470
CN - Cina 377
IE - Irlanda 348
FR - Francia 308
KR - Corea 247
GB - Regno Unito 172
PL - Polonia 157
RU - Federazione Russa 156
SE - Svezia 116
FI - Finlandia 105
MX - Messico 91
ES - Italia 55
AU - Australia 51
IN - India 44
CA - Canada 36
NL - Olanda 32
TR - Turchia 32
VN - Vietnam 30
CO - Colombia 28
BR - Brasile 26
JP - Giappone 26
CH - Svizzera 23
KG - Kirghizistan 22
PE - Perù 21
BE - Belgio 20
HK - Hong Kong 20
CL - Cile 18
EC - Ecuador 15
NZ - Nuova Zelanda 15
HU - Ungheria 14
ID - Indonesia 13
IR - Iran 13
EU - Europa 12
RO - Romania 12
DK - Danimarca 11
MY - Malesia 11
PH - Filippine 11
TH - Thailandia 11
AR - Argentina 9
CZ - Repubblica Ceca 9
BG - Bulgaria 8
PK - Pakistan 8
BO - Bolivia 7
CR - Costa Rica 7
GR - Grecia 7
EG - Egitto 6
TW - Taiwan 6
GT - Guatemala 5
ZA - Sudafrica 5
IQ - Iraq 4
AT - Austria 3
DO - Repubblica Dominicana 3
IL - Israele 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AM - Armenia 2
BD - Bangladesh 2
CM - Camerun 2
EE - Estonia 2
JO - Giordania 2
MD - Moldavia 2
ME - Montenegro 2
PR - Porto Rico 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
HN - Honduras 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
Totale 44.311
Città #
Wilmington 11.061
Woodbridge 10.987
Houston 9.987
Fairfield 804
Chandler 724
Ann Arbor 586
Singapore 543
Jacksonville 409
Ashburn 397
Dublin 326
Seattle 276
Cambridge 265
Medford 246
Dearborn 215
Rome 198
Beijing 176
Kraków 153
New York 126
Santa Clara 119
Lawrence 117
Redwood City 104
Milan 89
Menlo Park 80
San Diego 51
Mülheim 38
Mountain View 33
Falls Church 32
Bologna 31
Florence 30
Zhengzhou 27
Boardman 26
Palo Alto 26
Bari 23
London 23
University Park 23
Moscow 22
Naples 22
Dong Ket 20
Verona 20
Kunming 19
Lima 19
Nanjing 18
Guangzhou 17
Padova 17
Palermo 17
Barcelona 16
Brussels 16
Modena 16
Santiago 15
Kansas City 14
Norwalk 14
Sydney 14
Toronto 14
Budapest 13
Detroit 13
Bogotá 12
Dallas 12
Hefei 12
Helsinki 12
Hong Kong 12
Napoli 12
Ankara 11
Hamilton 11
Nishi 11
Phoenix 11
Pisa 10
Trieste 10
Turin 10
Wuhan 10
Zurich 10
Madrid 9
Melbourne 9
Mexico 9
Nürnberg 9
Veracruz 9
Amsterdam 8
Fuzhou 8
Campegine 7
Creede 7
Genova 7
Istanbul 7
Jinan 7
Messina 7
Parma 7
Quito 7
Redmond 7
Salerno 7
San Mateo 7
Shanghai 7
Vicenza 7
Genoa 6
Honolulu 6
Indiana 6
La Paz 6
Lahaina 6
Munich 6
Perugia 6
Seoul 6
Torino 6
Washington 6
Totale 39.065
Nome #
Validation of the Composite Autonomic Symptom Score 31 (COMPASS 31) for the assessment of symptoms of autonomic neuropathy in people with diabetes 1.103
Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation 821
Neuropatia Diabetica 587
Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy 510
Neuropatia Diabetica 490
Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction? 482
Raccomandazioni sull’uso dei test cardiovascolari nella diagnosi di neuropatia autonomica diabetica 467
Common polymorphisms in MIR146a, MIR128a and MIR27a genes contribute to neuropathy susceptibility in type 2 diabetes 463
Il trattamento della psoriasi nell’adulto. Linea guida 25. 463
Diagnostic value of different autonomic symptoms assessed by COMPASS 31 for cardiovascular autonomic neuropathy and diabetic polyneuropathy 460
Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients? 440
Long-term outcomes of diabetic patients with critical limb ischemia followed in a tertiary referral diabetic foot clinic 440
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 439
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 437
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 433
Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy 431
Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients. 430
TCF7L2 gene polymorphisms and type 2 diabetes: Association with diabetic retinopathy and cardiovascular autonomic neuropathy 429
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 426
Association between a MIR499A polymorphism and diabetic neuropathy in type 2 diabetes 426
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 422
Factors determining the 24-h blood pressure profile in normotensive patients with type 1 and type 2 diabetes 422
Influence of glucoregulation with continuous subcutaneous insulin infusion on nerve conduction velocity and beat to beat variation in diabetics 422
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 419
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 418
Diagnosis of cardiovascular autonomic neuropathy in diabetes 413
1965-2015, 1991-2015. 50 years of the EASD, 25 years of Neurodiab. Enduring friendship. A legacy for the future 413
Twenty-four-hour pattern of blood pressure and spectral analysis of heart rate variability in diabetic patients with various degrees of autonomic neuropathy. Comparison to standard cardiovascular tests. 412
Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. 410
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 410
Combination Therapy in Diabetic Neuropathy 410
Neuropatia e assistenza al diabetico 409
Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy 407
Change in glucose metabolism after long-term treatment with deflazacort and betamethasone 406
Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy 405
Effects of somatostatin on established induced ketosis 403
The relationship of autonomic neuropathy to other diabetic complications 403
Neuropathy in chronic kidney disease 402
Recent advances in exploring the genetic susceptibility to diabetic neuropathy 401
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 398
Benfotiamine: Commentary and update on recent studies 398
Might genetics play a role in understanding and treating diabetic polyneuropathy? 398
Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes 397
Psychopathology and dietary restriction: A comparison between eating disorders and Type 1 diabetes 397
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 396
A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy 395
IS DN4 AS A SCREENING TOOL FOR NEUROPATHIC PAIN SUITABLE FOR PAINFUL DIABETIC POLYNEUROPATHY? 395
Perspectives in Diabetic Neuropathy: Update on Diagnostic Criteria and Treatment Options 394
Psychological treatments and psychotherapies in the neurorehabilitation of pain: Evidences and recommendations from the italian consensus conference on pain in neurorehabilitation 393
Study of conduction velocity in diabetic with autonomic neuropathy. 391
Carbohydrate metabolism in hypertension: influence of treatment 390
GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6). 387
Efficacy and safety of lacosamide in painful diabetic neuropathy 386
Autonomic neuropathy: Clinical and instrumental findings 382
Prevenzione degli eventi avversi correlati alla presenza di complicanze del diabete (ipotensione ortostatica, danno renale acuto da mezzo di contrasto e ulcere da pressione) 380
Neuropatia diabetica autonomica, pressione arteriosa e funzione renale (Valsalva Lecture) 379
Neuropatia diabetica in Italia 378
Management of painful diabetic neuropathy: guideline guidance or jungle? 376
Methods of investigation for cardiac autonomic dysfunction in human research studies 375
Painful and painless diabetic neuropathy: one disease or two? 375
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 373
Diabetic autonomic neuropathy 372
Need for pathogenetically oriented therapy of neuropathy in diabetes mellitus 372
MicroRNA genetic variations: association with type 2 diabetes 372
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 372
Sensory profiles of neuropathic pain in painful diabetic polyneuropathy 372
Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction 368
A Novel Association Between Nondipping and Painful Diabetic Polyneuropathy 368
Autonomic neuropathy and secondary hyperparathyroidism in uraemia 368
Clinical correlates of painful diabetic neuropathy and relationship of neuropathic pain with sensorimotor and autonomic nerve function 367
Prevalence and characteristics of neuropathic pain in painful diabetic polyneuropathy 367
Should we avoid the handgrip test in the assessment of cardiovascular autonomic neuropathy in diabetic patients? Exploratory factor analysis 366
Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities 364
Relationship between hyperfunction of antral G cells (AGCH) and autonomic neuropathy (AN) in diabetic patients 363
Il corretto iter diagnostico della Neuropatia Diabetica 362
Improvement in peripheral and autonomic neuropathy during 18 months of treatment with subcutaneous continuous insulin infusion in type 1 diabetics 361
Reply to Circulating erythropoietin in diabetes mellitus. 360
Neuropathic pain impact on sleep and circadian rhythm of blood pressure in painful diabetic polyneuropathy 356
Reappraisal of the diagnostic role of orthostatic hypotension in diabetes 354
Painful Diabetic Polyneuropathy: Approach to Diagnosis and Management 350
Le nuove frontiere della nutrizione. 349
Why not to use the handgrip test in the assessment of cardiovascular autonomic neuropathy among patients with diabetes mellitus? 345
Costruire l'identità del nutrizionista 343
Time for a Consensus Conference on pain in neurorehabilitation. 343
Microvascular complications in children and adolescents with type 1 diabetes 342
Terapia farmacologica della neuropatia diabetica dolorosa 339
Impaired alpha cell function in conditions with cortisol deficiency 337
Disfunzione autonomica gastro-enterica e genito-urinaria 335
Novità in Endocrinologia. Calcificazione vascolare e osteolisi nella neuropatia diabetica - il legame mancante è il RANK-L? 335
Screening e trattamento della neuropatia diabetica 335
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial 335
Position Statement sull’appropriatezza nella prescrizione degli esami di laboratorio in diabetologia 334
Validity of DN4 as a screening tool for neuropathic pain of painful diabetic polyneuropathy 333
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 331
Glycaemic control and gastric emptying 326
Comparative study of periferal and autonomic neuropathy in diabetes 324
Nondipping is a novel associated disorder of painful diabetic polyneuropathy 318
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 313
Blood Pressure Variability and Autonomic Dysfunction 310
The nerve axon reflex-vasodilation for the assessment of small nerve fibers' dysfunction in diabetic patients 309
Totale 40.087
Categoria #
all - tutte 78.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207.923 0 0 0 0 934 1.271 1.026 969 1.018 965 846 894
2020/20217.117 744 871 780 905 816 742 922 681 185 96 278 97
2021/20221.378 48 178 76 95 87 168 60 68 73 93 90 342
2022/20232.062 195 131 103 235 182 410 174 145 197 55 141 94
2023/20241.016 100 54 72 78 105 175 49 69 55 75 69 115
2024/20251.426 135 664 304 202 121 0 0 0 0 0 0 0
Totale 44.759